IMbrave 050: A Phase III trial of atezolizumab plus bevacizumab in high-risk hepatocellular carcinoma after curative resection or ablation

Stephen P. Hack, Jessica Spahn, Minshan Chen, Ann Lii Cheng, Ahmed Kaseb, Masatoshi Kudo, Han Chu Lee, Adam Yopp, Pierce Chow, Shukui Qin

Research output: Contribution to journalReview articlepeer-review

20 Scopus citations

Fingerprint

Dive into the research topics of 'IMbrave 050: A Phase III trial of atezolizumab plus bevacizumab in high-risk hepatocellular carcinoma after curative resection or ablation'. Together they form a unique fingerprint.

Medicine & Life Sciences